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Abstract
Introduction: Despite the strong appeal of ferritin as a magnetic resonance imaging (MRI) reporter for stem cell
research, no attempts have been made to apply this genetic imaging reporter in stem cells in an inducible manner,
which is important for minimizing the potential risk related to the constitutive expression of an imaging reporter.
The aim of the present study was to develop an inducible genetic MRI reporter system that enables the production
of intracellular MRI contrast as needed.
Methods: Ferritin heavy chain (FTH1) was genetically modified by adding a Tet-On switch. A C3H10T1/2 cell line
carrying Tet-FTH1 (C3H10T1/2-FTH1) was established via lentiviral transduction. The dose- and time-dependent
expression of FTH1 in C3H10T1/2 cells was assessed by western blot and immunofluorescence staining. The
induced “ON” and non-induced “OFF” expressions of FTH1 were detected using a 3.0 T MRI scanner. Iron
accumulation in cells was analyzed by Prussian blue staining and transmission electron microscopy (TEM).
Results: The expression of FTH1 was both dose- and time-dependently induced, and FTH1 expression peaked in
response to induction with doxycycline (Dox) at 0.2 μg/ml for 72 h. The induced expression of FTH1 resulted in a
significant increase in the transverse relaxation rate of C3H10T1/2-FTH1 cells following iron supplementation. Prussian
blue staining and TEM revealed extensive iron accumulation in C3H10T1/2–FTH1 cells in the presence of Dox.
Conclusions: Cellular MRI contrast can be produced as needed via the expression of FTH1 under the control of a Tet-On
switch. This finding could lay the groundwork for the use of FTH1 to track stem cells in vivo in an inducible manner.
Keywords: Magnetic resonance imaging, Ferritin heavy chain, Reporter gene, Stem cells, Tetracycline inducible
expression system
Introduction
Stem cells, which exhibit the capacity to differentiate
into a diverse range of specialized cell types, have been
widely applied in the treatment of human diseases, in-
cluding cardiovascular, bone degenerative, autoimmune,
and neurodegenerative diseases [1–6]. Along with the
development of stem cell therapy for clinical practice, it
is crucial to visualize and track cells efficiently to evaluate
and improve this therapeutic approach [1, 7]. Traditional
histopathologic methods, which require repeated biopsies
or euthanasia and the removal of tissue for cell detection
in animal studies, cannot be completely applied to patients
[7, 8]. Therefore, there is an urgent need to develop non-
invasive imaging tools that enable the longitudinal assess-
ment of the viability, proliferation, lineage differentiation,
and functional integration of cell grafts.
Several imaging techniques have been investigated for
monitoring grafted cells in vivo. Optical imaging tech-
niques, such as bioluminescence imaging [9] and fluores-
cence imaging [10], have been used to track cell grafts in
* Correspondence: cai_jinhua@126.com
1Department of Radiology, Children’s Hospital of Chongqing Medical
University, 136 Zhongshan 2 Road, Yuzhong District, Chongqing 400014,
China
2Ministry of Education Key Laboratory of Child Development and Disorders,
136 Zhongshan 2 Road, Yuzhong District, Chongqing 400014, China
Full list of author information is available at the end of the article
© 2015 He et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
He et al. Stem Cell Research & Therapy  (2015) 6:207 
DOI 10.1186/s13287-015-0205-z
small animals. However, optical imaging shows that the
sensitivity and spatial resolution deteriorate more rapidly
in deeper tissues due to light scattering, which is not
feasible in large animals [3, 8, 11]. The imaging of
radionuclide-labeled cells using single-photon emission
computed tomography (SPECT) or positron emission tom-
ography (PET) has also been applied to track stem cell
grafts. One serious disadvantage of this technique is that
PET and, particularly, SPECT have inferior spatial reso-
lution [12]. In addition, frequent injections of radioactive
tracers are needed to obtain timely data about the cell
grafts [3]. Compared with radionuclide-based or optical
imaging, magnetic resonance imaging (MRI) has been pro-
posed as an ideal technique to monitor cells because of its
high spatial resolution and soft tissue contrast [1, 6, 13].
To date, MR imaging of stem cells has relied on the
cellular contrast generated by two major principles: dir-
ect labeling and indirect labeling (based on MRI reporter
gene expression) [14, 15]. Direct cell labeling refers to
the strategy of loading cells with contrast agents prior to
engraftment into the host. Due to their high relaxivity,
superparamagnetic iron oxide nanoparticles (SPIOs)
have been the most widely used contrast agents for
tracking various cell types [3, 12, 15–18]. However, long-
term tracking of engrafted cells is not possible when
using this direct labeling approach because the concen-
tration of the contrast agent in the cells continuously
decreases as they divide [16, 19, 20]. Moreover, the MRI
signal produced by these agents does not reflect the
actual cell number because the cells can continue to
proliferate and divide asymmetrically [3, 21]. In addition,
the MRI signal from magnetic nanoparticles does not
represent the number of live cells because particles re-
leased from dead cells can be phagocytosed by host cells,
thereby misleading MRI tracking [2, 22, 23]. To circum-
vent these shortcomings, it is necessary to use a genetic
MRI reporter system, in which the cells to be implanted
are transfected with reporter genes that are integrated
into the genome, expressed in a sustainable manner, and
ultimately translated into traceable products, resulting in
MRI contrast in the transplanted cells.
Several genetic MRI reporting systems have been in-
vestigated, including divalent metal transporters [24, 25],
β-galactosidase [26], tyrosinase [27], transferrin receptor
[28], magA [29, 30] and ferritin [31, 32]. Among these
candidates, ferritin, which displays a high transverse
relaxation rate by inducing the expression of the trans-
ferrin receptor and increasing iron uptake, has been
widely used as a reproducible and functional MRI
reporter in extensive molecular imaging studies [2, 33].
Ferritin is a ubiquitous intracellular iron storage protein
consisting of 24 heavy (H) and light (L) subunits, and it
is essential for cellular iron metabolism [19, 34, 35]. One
candidate major regulator of ferritin activity was identified
as ferritin heavy chain (FTH1), which displays ferroxidase
activity to promote iron oxidation and incorporation [36].
FTH1 alone or in conjunction with ferritin light chain has
been previously reported to function as an MRI reporter
[37, 38]. In contrast to SPIOs and other particles, the gen-
etically modified transgene of FTH1 would not be diluted
as cells divide. In this regard, the continuous production
of FTH1 in the daughter cells offers a significant ad-
vantage for cell tracking via MRI compared with
particle-based cell labeling methods [2, 39]. Thus far,
few studies have focused on FTH1 as an emerging re-
porter. These studies showed that the overexpression
of FTH1 alters the MRI signal at its expression site
and enables cell tracking via MRI.
Despite the strong appeal of FTH1 as an MRI reporter
for stem cell research, no attempts have been made to
apply this imaging reporter in stem cells in an inducible
manner, which is important for minimizing the potential
toxicity caused by the constitutive expression of the
imaging reporter. In our study, C3H10T1/2 stem cells
were transduced with FTH1 as a MRI reporter, which
was regulated by a Tet-On switch. Our aim was to
minimize the potential risk of the persistent overexpres-




Wild type C3H10T1/2 cells (C3H10T1/2-WT; kindly
gifted by the Molecular Cancer Laboratory of the Univer-
sity of Chicago in the United States), a murine mesenchy-
mal stem cell line, were grown in Dulbecco’s Modified
Eagle’s Medium (DMEM; Gibco, Grand Island, NY, USA)
supplemented with 10 % fetal bovine serum (FBS;
Hyclone, Logan, UT, USA) and 0.5 % streptomycin at
37°C in 5 % CO2. The medium was changed daily,
and the cells were passaged every three days at a ratio of
1:3 to 1:5 by treating the cells with 0.25 % trypsin-EDTA
(Beijing Dingguo Biological Technology Co., Ltd., Beijing,
China), followed by dissociation into single cells.
Construction and transfection of recombinant
lentiviral vectors
To generate recombinant lentiviruses expressing a fusion
gene of FTH1 with a Flag tag under the control of a tetra-
cycline response element (TRE), human FTH1 (accession
number BC000857) cDNA was generated via polymerase




Then, this cDNA was subcloned into the multiple cloning
site of the pLenti-Tet-on-MCS-3Flag-Puro plasmid
using AgeI and EcoRI to yield the recombinant vector
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pLenti-Tet-on-FTH1-3Flag-Puro (pLV-Tet-FTH1). The pro-
duction of pLV-Tet-FTH1 was verified by PCR analysis and
DNA sequencing. A lentivirus expressing Tet-FTH1 (LV-Tet-
FTH1) was generated by co-transfecting pLV-Tet-FTH1 to-
gether with the packaging vector pHelper 1.0 and the envelope
vector pHelper 2.0 into 293 T packaging cells (Invitrogen,
Carlsbad, CA, USA). Fresh medium containing 10 % FBS was
added 10-14 h after transfection, and the viral medium was
collected at 48–72 h. C3H10T1/2 cells were infected with the
lentiviruses at 30–40 % confluence using polybrene (8 μg/ml)
(Sigma-Aldrich, St. Louis, MO, USA). A t 72 h post-
transduction, the medium was supplemented with 4 μg/ml
puromycin (Sigma-Aldrich, St. Louis, MO, USA) for selection
to generate a clonal cell line (C3H10T1/2-FTH1).
Western blot analysis
To examine the dose-dependent expression of FTH1,
C3H10T1/2-FTH1 cells were cultured in medium containing
doxycycline (Dox; Santa Cruz, Dallas, TX, USA) at serial
concentrations (0, 0.02, 0.2, 0.6, 2, or 6 μg/ml) for 72 h. Then,
the time point of peak FTH1 expression was determined by
culturing the cells in medium containing the optimal con-
centration of Dox for different durations. After treatment,
the cells were washed with ice-cold phosphate-buffered sa-
line (PBS, pH 7.4) and lysed in radioimmunoprecipitation
assay (RIPA) buffer (Beyotime, Nanjing, Jiangsu, China). The
lysates were heated at 100 °C for ten min and clarified by
centrifugation at 14,000 × rpm at 4 °C for 15 min. The total
protein concentration was determined using bicinchoninic
acid (BCA; Beyotime, Nanjing, Jiangsu, China) method. A
total of 30 μg of protein was separated via 12 % gradient
SDS-polyacrylamide gel electrophoresis (SDS-PAGE;
Beyotime, Nanjing, Jiangsu, China) and transferred to
polyvinylidene fluoride (PVDF) membranes (Millipore,
Madrid, Spain), which were then blocked with 5 % bovine
serum albumin (BSA, Sigma-Aldrich, St. Louis, MO,
USA) in Tris-buffered saline containing Tween-20
(TBST). The membranes were probed with primary
antibodies that specifically recognized FTH1 (rabbit anti-
FTH1, 1:1,000; Abcam, Cambridge, MA, UK) or β-actin
(mouse anti-β-actin; Nanjing Zoonbino Biotechnology Co.,
Ltd., Nanjing, Jiangsu, China) overnight at 4 °C. After wash-
ing several times, the membranes were incubated with sec-
ondary antibodies (anti-rabbit 1:5,000, Abgent, San Diego,
CA, USA; anti-mouse 1:1000, Genscript, Nanjing, Jiangsu,
China) and visualized using an enhanced chemiluminescence
kit (Beyotime, Nanjing, Jiangsu, China). FTH1 expression
was quantified and normalized to β-actin expression using
Quantity One 4.4 software (Bio-Rad, Hercules, CA, USA).
Immunofluorescence staining of cells
The Flag tag was used to indirectly determine the ex-
pression levels of FTH1 via immunocytochemistry using
a Flag-specific antibody. C3H10T1/2-FTH1 cells were
cultured for 72 h in the same concentrations of Dox as
those used in the western blot experiments. Then, the
cells were fixed in 4 % paraformaldehyde (PFA) for
15 min at room temperature. The fixative solution was re-
moved, and the cells were washed with PBS three times
for five min each. The cells were permeabilized with 1 %
Triton X-100 in PBS for ten min, blocked with 5 % BSA in
PBS at 37 °C for 30 min to 1 h, and then incubated
in a specific primary antibody (mouse anti-Flag 1:200;
Sigma-Aldrich, St. Louis, MO, USA) overnight at 4 °
C. After three washes with PBS, the cells were incu-
bated in a secondary antibody (Cy3-conjugated anti-
mouse, 1:1,000; Beyotime, Nanjing, Jiangsu, China) for
30-45 min at 37 °C. Nuclei were counterstained with
4,6-diamidino-2-phenylindole (DAPI; Beyotime, Nanjing,
Jiangsu, China) for five min. Images were acquired using a
biological fluorescence microscope (Nikon, Tokyo, Japan).
Cellular MRI
To determine the suitable concentration of iron supple-
mentation to produce cellular MRI contrast in the pres-
ence of FTH1 expression, C3H10T1/2-FTH1 cells were
cultured in varying concentrations of ferric ammonium
citrate (FAC; Sigma-Aldrich, St. Louis, MO, USA) in the
presence or absence of 0.2 μg/ml Dox for 72 h. Then,
the following six treatments of C3H10T1/2-FTH1 cells
were prepared: (1) no Dox or FAC; (2) no Dox and 500
μM FAC; (3) 0.2 μg/ml Dox and no FAC; (4) 0.2 μg/
ml Dox and 500 μM FAC; (5) 6 μg/ml Dox and no FAC;
and (6) 6 μg/ml Dox and 500 μM FAC. After treatment
for 72 h, the cells were thoroughly washed and dissociated
with trypsin, followed by fixation in 4 % PFA for 15
min. Each group of cells (3-5 × 107 cells) was centri-
fuged at 1,000 rpm for five min, and the supernatant
was removed. Then, the cells were resuspended in
100 μl of PBS and carefully placed in 0.5-ml Eppen-
dorf tubes. The cells settled and formed a loose pellet
at the bottom of the tubes. All MRI scans were per-
formed using a clinical 3.0 T MRI scanner (Phillips,
Eindhoven, Netherlands). The multi-slice and multi-
echo sequence was used for T2 mapping in vitro. The
imaging parameters were as follows: time of repetition
(TR) = 2,000 ms, time of echo (TE) = 13-78 ms with a
step size of 13 ms (six-point T2 mapping), field of
view (FOV) = 160 × 160 mm, image matrix = 380 × 311,
and slice thickness = 1 mm. R2 values were measured
from R2 color maps, which were merged with the
anatomical images acquired at the shortest TE.
Prussian blue staining of cells
Prussian blue staining was used to assess iron accumula-
tion in stem cells. C3H10T1/2-WT or C3H10T1/2-FTH1
cells cultured on poly-L-lysine-coated coverslips were
treated as follows: no Dox or FAC (Dox-/FAC-); no Dox
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and 500 μM FAC (Dox-/FAC 500); or 0.2 μg/ml Dox and
500 μM FAC (Dox 0.2/FAC 500). After incubation for
72 h, the cells were washed thoroughly in PBS and
fixed in 4 % PFA for 15 min before staining. The cov-
erslips were placed in staining solution (2 % potassium
ferrocyanide and 2 % HCl) for 30 min at room
temperature. After three washes with PBS, the cells were
counterstained with nuclear fast red and mounted on
slides using water-soluble mounting medium. In this
assay, the presence of iron was indicated as a bright blue
color displaying a granular cytoplasmic distribution.
Transmission electron microscopy of cells
C3H10T1/2-WT and C3H10T1/2-FTH1 cells were
treated as described for Prussian blue staining. At least
1.5 × 106 cells were fixed in 3 % glutaraldehyde-
cacodylate buffer at 4 °C overnight. After incubation for
1 h in 1 % OsO4, the cells were dehydrated in a graded
ethanol series and embedded in artificial Epon resin
(Hexion, Shanghai, China). Unstained thin sections of
the cells were evaluated for FAC endocytosis using a H-
7500 transmission electron microscope (Hitachi, Tokyo,
Japan).
Assessment of cell proliferation
To assess whether FTH1 expression or FAC is detrimental
to cell growth, 5 × 103 C3H10T1/2-WT and C3H10T1/2-
FTH1 cells per well treated with 0.2 μg/ml Dox, 500 μM
FAC, or both were plated in a 96-well plate and incubated
for 72 h. Then, cell proliferation was measured via a Cell
Counting Kit-8 (CCK-8) assay according to the manufac-
turer's instructions (Beyotime). To further address the ad-
verse impact of Dox on cell growth, the cells were treated
with varying concentrations of Dox for 72 h, and cell pro-
liferation was determined using the same assay. Changes
relative to the untreated group were calculated for both
cell lines. The absorbance was measured at a wavelength
of 450 nm, and these values were subtracted from the
absorbance values at the reference wavelength of 650 nm.
Statistical analysis
All data are expressed as the means ± SD of at least five
independent experiments. Statistical analyses were
completed using a two-tailed unpaired Student’s t-test.
P-values less than 0.05 were considered statistically
significant.
Results
Expression of FTH1 induced by Dox in C3H10T1/2-FTH1 cells
To express FTH1 only at the time of MRI performance,
the FTH1 gene was cloned into a Dox-inducible lenti-
viral vector, and a Flag tag was fused to the 3’ end of the
FTH1 gene. Then, the expression of FTH1 carrying the
Flag tag was under the control of a Tet-On switch.
Puromycin, an antibiotic-resistant gene, was expressed
via the internal ribosome entry site (IRES) down-
stream of reverse tetracycline-controlled transactivator
(rtTA) and was regulated by the human ubiquitin (Ubi) pro-
moter. The resulting lentiviral vector carrying FTH1 under
the control of a Tet-On switch (LV-Tet-FTH1) is illustrated
in Fig. 1. This high-titer lentivirus, which was prepared as
described above, was used to transfect C3H10T1/2 cells,
followed by clonal selection using puromycin. Then,
C3H10T1/2 cells expressing Tet-FTH1 (C3H10T1/2-FTH1)
were successfully established for subsequent studies.
To examine the dose-dependent expression of FTH1,
C3H10T1/2-FTH1 cells were cultured in medium
containing Dox at different concentrations for 72 h, and
different levels of FTH1 expression were detected by
western blot analysis. FTH1 expression peaked at a Dox
concentration of 0.2 μg/ml and decreased at higher Dox
concentrations. FTH1 expression was completely re-
pressed at a Dox concentration of 6 μg/ml (Fig. 2a). For
the time-dependent expression of FTH1, C3H10T1/2-
FTH1 cells in the absence of Dox were transferred to
medium containing 0.2 μg/ml Dox and incubated for
different durations. The results showed that the FTH1
expression level increased gradually to its peak at 72 h
and then decreased gradually (Fig. 2b). Furthermore,
immunostaining using a Flag-specific antibody demon-
strated that Flag expression peaked in C3H10T1/2-
FTH1 cells upon induction with 0.2 μg/ml Dox for 72 h
(Fig. 3); this result is consistent with the western blot re-
sults. Neither FTH1 nor Flag expression was detectable
in the absence of Dox. Based on protein expression, a
Dox concentration of 0.2 μg/ml and a duration of 72 h
were used as the optimal induction conditions to achieve
maximal FTH1 expression in subsequent studies.
MRI contrast generated via the induced expression of FTH1
The results showed no significant changes in the MRI
signal in the absence of Dox (Dox-); however, there was
a significant decrease in the MRI signal in the presence
of Dox (Dox+) and 500 μM FAC. Although further in-
creasing the FAC concentration additionally reduced the
MRI signal, 500 μM FAC was used in the subsequent in
vitro MRI experiments considering the side effects of a
high FAC concentration on the cells (Fig. 4a). We fur-
ther measured the changes in R2 in C3H10T1/2-FTH1
cells incubated in Dox at different concentrations in the
presence or absence of 500 μM FAC for 72 h. The
results demonstrated a marked increase in R2 in
C3H10T1/2-FTH1 cells treated with Dox and FAC
(0.2 μg/ml and 500 μM, respectively) compared with
that in the other cells (P < 0.05) (Fig. 4b). These re-
sults indicated that the resulting MRI contrast could
be correlated with gene expression via Dox adminis-
tration and iron supplementation.
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Evaluation of cell proliferation
To determine the impact of expressing FTH1 on cells, we
evaluated the cell proliferation rate via the CCK-8 assay.
The results revealed that maximal FTH1 expression did
not interfere with C3H10T1/2 cell proliferation in vitro,
even in the presence of iron supplementation. However,
we observed that supplementation of the cell medium
with FAC at a high dose (500 μM) inhibited the growth of
both C3H10T1/2-WT cells in the presence or absence of
Dox and C3H10T1/2-FTH1 cells only in the absence of
Dox (P < 0.05). These observations indicated that the high
iron concentration was toxic to the wild type cells but not
the cells overexpressing FTH1 (Fig. 5a). Supplementation
of the cell medium with a low concentration of FAC
(5 μM) did not affect wild type or transduced cell
growth in the presence or absence of 0.2 μg/ml Dox
(data not shown). In summary, in our study, FTH1
overexpression did not affect C3H10T1/2 cell prolifera-
tion, and FTH1 increased the resistance to iron toxicity.
We further addressed the side effects of Dox on cell
growth using the same method. The growth rate of
C3H10T1/2-FTH1 cells was not significantly different
from that of C3H10T1/2-WT cells at corresponding Dox
concentrations of 0.2 μg/ml or 0.8 μg/ml. However,
C3H10T1/2-FTH1 cells demonstrated a significantly
lower growth rate than did C3H10T1/2-WTcells at a Dox
concentration of 2 μg/ml (P < 0.001, n = 5). At higher Dox
concentrations, the growth rate of both C3H10T1/2-
FTH1 and C3H10T1/2-WT cells negatively correlated
with the Dox concentration, although C3H10T1/2-FTH1
cells were more sensitive to these concentrations of Dox
than were C3H10T1/2-WTcells (Fig. 5b).
Iron accumulation in C3H10T1/2 cells following the
induced expression of FTH1
Prussian blue staining confirmed more significant ac-
cumulation of iron in the C3H10T1/2-FTH1 cells
than in the C3H10T1/2-WT cells in the same Dox-/FAC-
supplemented medium (0.2 μg/ml Dox and 500 μM FAC).
In the absence of Dox, neither C3H10T1/2-FTH1 nor
C3H10T1/2-WT cells showed obvious blue staining parti-
cles regardless of FAC supplementation (Fig. 6a). TEM re-
vealed results similar to those of Prussian blue staining
(Fig. 6b). Extensive iron particles accumulated in the cyto-
plasmic vacuoles of C3H10T1/2-FTH1 cells cultured in
the presence of 0.2 μg/ml Dox and 500 μM FAC. How-
ever, the cells (C3H10T1/2-WT and C3H10T1/2-FTH1)
cultured in control medium did not show any iron accu-
mulation. These results indicated that FTH1 overexpres-
sion may trigger an increase in the capacity of the cell to
internalize and store iron when iron is available.
Discussion
Using an inducible Tet-On system to express the genetic
MRI reporter FTH1, we successfully developed a noninva-
sive, repeatable and controllable imaging tool for stem
Fig. 1 Schematic illustration of LV-Tet-FTH1. A flag tag was fused to the 3’ end of the FTH1 gene. The expression of Flag-tagged FTH1 was under
the control of a tetracycline response element (TRE). The antibiotic resistance gene puromycin was expressed via the internal ribosome entry site
(IRES) downstream of reverse tetracycline-controlled transactivator (rtTA) and was regulated by the human ubiquitin (Ubi) promoter. LV-Tet-FTH1
lentiviruses expressing Tet-FTH1 FTH1 ferritin heavy chain
Fig. 2 Western blot assay of doxycycline-regulated FTH1 expression. a Dox dose-dependent FTH1 expression: C3H10T1/2-FTH1 cells were cultured
in medium containing Dox at different concentrations for 72 h. With increasing Dox concentration, the FTH1 expression level increased, peaked
at a Dox concentration 0.2 μg/ml, and then decreased at higher Dox concentrations. FTH1 expression was completely repressed at a Dox concentra-
tion of 6 μg/ml. b Time-dependent FTH1 expression: C3H10T1/2-FTH1 cells were cultured in medium containing Dox (0.2 μg/ml) for different dura-
tions. With increasing time, the FTH1 expression level increased gradually to its peak at 72 h and then decreased gradually. FTH1 ferritin heavy chain,
Dox doxycycline
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cells. By employing this newly created system, we visual-
ized these stem cells via MRI in a controlled manner
during the Dox induction time window. More import-
antly, this Tet-On switch-controlled genetic MRI reporter
system efficiently reduced the potential risk caused by the
continuous expression of FTH1 and the accumulation of
iron in stem cells.
The potential adverse impacts of persistent FTH1
expression and iron accumulation on cellular iron
homeostasis and cell growth warrant concern. In our
study, a 500 μM concentration of iron supplement
reduced the growth rate of both C3H10T1/2-WT and
C3H10T1/2-FTH1 stem cells in the absence of Dox (i.e.,
no FTH1 expression) but did not reduce the growth rate
of C3H10T1/2-FTH1 stem cells in the presence of Dox
(i.e., during FTH1 expression). This finding indicated
that FTH1 expression can protect against reactive
oxygen species, possibly via a mechanism involving the
sequestering of excess iron [40]. These results agree with
the study by Naumova et al. [2], in which the supple-
mentation of the cell medium with FAC at a high dose
(1 mM) inhibited the proliferation of wild type and
transduced C2C12 cells; their study also revealed that
exogenous iron was more toxic to wild type cells than to
cells overexpressing ferritin. However, other authors
have presented contrasting results. One study found that
the growth of C6 glioma cells was significantly reduced
when FTH1 expression was dramatically increased [16].
Another study indicated that the growth of HeLa cells
was significantly decreased by the overexpression of
FTH due to the induction of an iron-deficient phenotype
and that HeLa cell growth was recovered by administer-
ing iron [41]. Additionally, Feng et al. [19] demonstrated
that moderate overexpression of FTH1 did not affect
nasopharyngeal carcinoma (NPC) cell growth with or
without iron supplementation; moreover, the authors
showed that the maximal overexpression of FTH1 de-
creased the cell growth rate in the absence of iron sup-
plementation but that the cell growth rate remained
unchanged in the presence of iron supplementation,
which suggests that the expression level of FTH1 deter-
mined whether cell growth was affected. Based on the
above evidence, we conclude that the effects of FTH1 may
depend on the cell type and the FTH1 expression level.
In general, the accumulation of iron may have side
effects in target cells because an excess of labile iron in
cells is known to cause increased oxidative stress via
Fenton and Haber–Weiss reactions, resulting in DNA,
lipid, and protein damage [34]. Although FTH1 is con-
sidered a resistance factor to intracellular free iron, the
intracellular free iron levels may exceed the sequestering
capacity of persistently overexpressed FTH1. In addition,
with iron transferred into the cells, the extracellular iron
concentration could be reduced to varying degrees,
thereby influencing iron homeostasis in the local tissue
and even the entire body. We adopted an inducible Tet-
On system in the present study, and we revealed that
the expression of FTH1 could be controlled as needed.
This method efficiently reduced the potential risk of
persistent FTH1 overexpression and iron accumulation
in cells, which is essential to the application of FTH1 as
a MRI reporter for tracking transplanted cells in vivo.
The present study revealed that FTH1 expression was
dose- and time-dependent upon Dox administration. In
the dose-dependence experiment, western blot analysis
showed no FTH1 expression in C3H10T1/2-FTH1 cells
Fig. 3 Immunostaining of doxycycline-regulated Flag expression in C3H10T1/2-FTH1 cells. The cells were grown in different concentrations of
Dox for 72 h. Immunostaining using a Flag-specific antibody demonstrated that with increasing Dox concentration, the expression of Flag in
C3H10T1/2-FTH1 cells increased and peaked upon induction with 0.2 μg/ml Dox for 72 h and then decreased (red); this result is consistent
with the western blot results. The nucleus was visualized via DAPI staining (blue). Bar = 50 μm. FTH1 ferritin heavy chain, Dox doxycycline,
DAPI 4,6-diamidino-2-phenylindole
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in the absence of Dox, indicating that there was no back-
ground leakage of gene expression in the tetracycline-
regulated lentiviral vector system. At increasing Dox
concentrations, FTH1 expression increased and peaked
at 0.2 μg/ml Dox. Based on this result, the optimal incu-
bation time of 72 h was obtained from the time-
dependence experiment. In addition, immunostaining
using a Flag-specific antibody demonstrated that the
expression of Flag peaked in C3H10T1/2-FTH1 cells
induced with 0.2 μg/ml Dox for 72 h. This finding was
consistent with the western blot results. Thus, the
expression of FTH1 in C3H10T1/2-FTH1 cells was
efficiently switched on by adding a suitable dose of Dox
for the appropriate duration. We further addressed the
impact of Dox on cell growth. The proliferation rate of
both C3H10T1/2-FTH1 and C3H10T1/2-WT cells
negatively correlated with the Dox concentration, al-
though C3H10T1/2-FTH1 cells were more sensitive to
Dox than C3H10T1/2-WT cells. However, 0.2 μg/ml
Dox, which resulted in maximal FTH1 expression, had a
negligible impact on cell viability.
Notably, compared to ex vivo direct cell-labeling
methods, such as using SPIOs, the genetic MRI reporter
method provides much weaker MRI contrast [3, 16].
However, SPIOs can subsequently become diluted,
thereby reducing their signal, due to cell division. More-
over, recent studies have shown that SPIOs may have an
adverse impact on cell differentiation [42–44]. Thus, we
expect that exogenous labeling methods might be help-
ful for monitoring differentiated cells, especially cells
that exhibit a slow proliferation rate for a relatively short
period. However, for tracking stem cells or progenitor
Fig. 4 MRI contrast generated via the induced expression of FTH1. a C3H10T1/2-FTH1 cells were cultured for 72 h in the presence or absence of
0.2 μg/ml Dox and different concentrations of FAC for T2-weighted imaging. In the absence of Dox (Dox-), there was no significant MRI signal
change. However, in the presence of Dox (Dox+), the MRI signal decreased with increasing iron concentrations, and the MRI signal was significantly
decreased at iron concentrations of 500 μM and 800 μM. b C3H10T1/2-FTH1 cells were cultured in Dox at different concentrations in the presence or
absence of 500 μM FAC for 72 h. Color-coded R2 maps from multi-echo measurements of the R2 relaxation rates showed a significant increase in the
R2 rate in C3H10T1/2-FTH1 cells treated with Dox and FAC (0.2 μg/ml and 500 μM, respectively) compared to that in the other cells (P < 0.05). MRI
magnetic resonance imaging, FTH1 ferritin heavy chain, Dox doxycycline, FAC ferric ammonium citrate
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cells with high proliferation and differentiation capacity,
MRI reporters have a clear advantage over direct cell-
labeling methods.
To date, a few MRI reporting systems have been in-
vestigated. Most of these genetic reporters were de-
veloped to track metastatic cancer cells, and only
ferritin and magA have been reported with respect to
monitoring stem cell grafts. Some studies have yielded
evidence that the expression of magA can produce
magnetite particles to augment MRI contrast [29, 45, 46].
Following magA expression, cell pellets consistently
showed an increase in R2 of approximately three- to
four-fold, compared with an increase in R2 of ap-
proximately 2.5-fold following ferritin expression [45].
However, in a recent study, Uebe et al. [47] indicated
that magA is not involved in magnetosome formation;
the authors proposed that the magnetosome gene is-
land contains all essential genes required for magne-
tosome formation and that these genes might have
been distributed by horizontal gene transfer. Com-
pared with the pre-labeling approach and the use of
other genetic MRI reporters described previously,
FTH1 is the most attractive option for longitudinal
MRI monitoring of molecular events. The results of
the present study showed that the expression of
FTH1 is tightly regulated by Dox in C3H10T1/2 stem
cells. Using this inducible MRI reporter gene, the
intracellular iron level was detectable using a clinical
3.0 T MRI system.
T2-weighted imaging presumably provides a more
accurate representation of the spatial extent of the
cells, although T2*-weighted imaging is more sensi-
tive [45]. In our study, we were able to detect
C3H10T1/2-FTH1 cells via T2-weighted imaging ra-
ther than T2*-weighted imaging. As expected, the R2
relaxation rate was significantly increased when
C3H10T1/2-FTH1 cells were treated with Dox and
FAC for the optimal period. Transverse relaxivity
linearly increases with increasing magnetic field
strength; therefore, we would expect more effective
visualization of FTH1-tagged cells or grafts at higher
magnetic field strengths.
Knowing the fate of the FTH1-tagged stem cells
along the differentiation pathway is important. A re-
cent study revealed that FTH1 does not alter the
multidifferentiation potential of stem cells. FTH1 is
expressed in differentiated cells as well as stem cells
[48]. Thus, distinguishing between these cell types
noninvasively is impossible via reporter gene imaging
with the present available technology, and we cannot
know whether the stem cells have differentiated into
specific cell lines in vivo. In further studies, a novel
imaging system should be developed to monitor and
evaluate the differentiation of stem cells.
Conclusions
In general, this study reports the first use of MRI for
the detection of FTH1 gene expression in C3H10T1/2
stem cells in an inducible manner. In this study, we
developed an inducible genetic MRI reporter system
Fig. 5 Evaluation of cell proliferation. a To determine the impact of
FTH1 expression on cells, the proliferation of treated cells (5 × 103)
cultured in a 96-well plate for 72 h was assessed using Cell Counting
Kit-8 (CCK-8). A high dose of FAC (500 μM) inhibited the growth of
both C3H10T1/2-WT cells in the presence or absence of Dox and
C3H10T1/2-FTH1 cells only in the absence of Dox (P < 0.05). However,
maximal FTH1 expression did not interfere with C3H10T1/2 cell
proliferation in vitro, even in the presence of iron supplementation.
b The impact of Dox on cell growth was also determined using CCK-8.
There was no significant suppression of cell growth at a Dox
concentration of 0.8 μg/ml. However, significant suppression of
the growth of C3H10T1/2-FTH1 cells compared with C3H10T1/2-WT
cells was detected at a Dox concentration of 2 μg/ml (P < 0.001, n = 5).
At higher concentrations of Dox, the proliferation of both
C3H10T1/2-WT and C3H10T1/2-FTH1 cells negatively correlated
with the Dox concentration, although the C3H10T1/2-FTH1 cells
showed a slightly steeper negative linear correlation than did the
C3H10T1/2-WT cells. FTH1 ferritin heavy chain, FAC ferric ammonium
citrate, Dox doxycycline
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in which FTH1 is expressed under the control of a
Dox-sensitive Tet-On switch. In C3H10T1/2 stem
cells carrying this FTH1-Tet system, FTH1 expression
was undetectable at the baseline but was strongly
induced upon treatment with Dox. This increase in
FTH1 expression resulted in substantial iron accumu-
lation and clearly detectable MRI contrast in these
cells. Potential future applications of this inducible
MRI reporter system include tracking the transplanted
stem cells by triggering reporter gene expression via
the addition of a suitable dose of Dox only when
MRI is needed. This method could efficiently reduce
the potential risk caused by the persistent expression
of this reporter gene and the constitutive accumula-
tion of iron in cells.
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Fig. 6 Intracellular iron accumulation following induced FTH1 expression. a Prussian blue staining: In the presence of 0.2 μg/ml Dox and 500 μM
FAC, a large number of blue iron particles were detected in the C3H10T1/2-FTH1 cells, but no iron particles were detected in the C3H10T1/2-WT
cells. In the absence of Dox, neither C3H10T1/2-FTH1 nor C3H10T1/2-WT cells showed blue iron particles, regardless of FAC supplementation.
b Transmission electron microscopy: In the presence of 0.2 μg/ml Dox and 500 μM FAC, numerous electron dense particles were detected in the
cytoplasm of C3H10T1/2-FTH1 cells, but no particles were detected in C3H10T1/2-WT cells. In the absence of Dox, neither C3H10T1/2-FTH1 nor
C3H10T1/2-WT cells showed electron dense particles, regardless of FAC supplementation. Scale bars: 50 μm (a) and 2 μm (b). FTH1 ferritin heavy
chain, Dox doxycycline, FAC ferric ammonium citrate
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